🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
This is a Phase 1, randomized, controlled, dose-ranging clinical trial to a...
Status
Not Yet Recruiting
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2026-08-07
Trial ID
NCT07703514
The purpose of this study is to assess the reactogenicity, safety and immun...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2025-10-07
Trial ID
NCT07204964
This is a Phase 1, single-site, open-label, comparator-controlled dose esca...
Status
Completed
Location
Duke Vaccine and Trials Unit
Start Date
2023-04-05
Trial ID
NCT05755620
This study will evaluate the reactogenicity, safety, and immune response of...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-11-11
Trial ID
NCT06680375
The purpose of this study is to evaluate the safety and efficacy of mRNA-10...
Status
Completed
Location
North Alabama Research Center, LLC
Start Date
2022-09-14
Trial ID
NCT05566639
Treatments Being Tested
This is a Phase 1, single-site, comparator-controlled, dosage-escalating st...
Status
Completed
Location
University of Iowa - Infectious Disease Clinic
Start Date
2023-10-16
Trial ID
NCT05945485
This study will assess the safety and immunogenicity of a fourth dose (boos...
Status
Completed
Location
Northern Beaches Clinical Research
Start Date
2022-04-20
Trial ID
NCT05310084
Treatments Being Tested
The main goal of this study is to evaluate the safety, reactogenicity, and ...
Status
Completed
Location
CenExel
Start Date
2022-05-24
Trial ID
NCT05397223
The purpose of this study is to find and confirm the dose and asses the rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-04-27
Trial ID
NCT05823974